Lymphoma Trials

TG Therapeutics UTX-TGR-205

A Phase 2b Randomized Study to Assess the Efficacy and Safety of the Combination of Ublituximab + TGR-1202 and TGR-1202 alone in Patients with Previously Treated Diffuse Large B-Cell Lymphoma   OPEN COHORTS: MANTLE CELL, FOLICULAR LYMPHOMA, Marginal Zone

Genentech GO40554

A phase I/II study of BTCT4465A in patients who do not achieve CR to 1L therapy for DLBCL and as 1L therapy for patients unfit to receive full-dose anthracycline-based chemotherapy Regulatory Packet sent to Sponsor.

TG Therapeutics TG-1501-101

A Phase 1 Study of TG-1501 in Subjects with Relapsed or Refractory Lymphoma

Aptose APTO-CG-806- 01

A Phase 1 a/b Trial to Evaluate the Safety and Tolerability of CG-806 in Patients with CLL/SLL or Non-Hodgkin’s Lymphomas

Fort Wayne North Office
(260) 484-8830
2514 E Dupont Road, Suite 100
Fort Wayne, IN 46825

Fort Wayne South Office
(260) 436-0800
7910 West Jefferson Boulevard, Suite 108
Fort Wayne, Indiana 46804

©2019 Fort Wayne Medical Oncology and Hematology. All Rights Reserved.